Advisornet Financial’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Buy
109
+1
+0.9% +$121 ﹤0.01% 1538
2026
Q1
$17.7K Sell
108
-814
-88% -$125K ﹤0.01% 1374
2025
Q4
$160K Buy
922
+815
+762% +$149K 0.01% 664
2025
Q3
$15.4K Buy
107
+27
+34% +$3.31K ﹤0.01% 1392
2025
Q2
$8.05K Buy
80
+73
+1,043% +$5.58K ﹤0.01% 1547
2025
Q1
$534 Buy
7
+1
+17% +$76 ﹤0.01% 1957
2024
Q4
$414 Buy
+6
New +$432 ﹤0.01% 1808
2024
Q1
Sell
-11
Closed -$341 2270
2023
Q4
$341 Buy
11
+3
+38% +$78 ﹤0.01% 2200
2023
Q3
$202 Buy
+8
New +$183 ﹤0.01% 2135
2023
Q2
Sell
-2
Closed -$34 2424
2023
Q1
$34 Buy
+2
New +$39 ﹤0.01% 2370

Other funds holding INSM

Advisornet Financial's INSM Position: Q2 2026 in Review

Advisornet Financial increased its Insmed (INSM) stake by 0.93% in Q2 2026, buying an estimated $121 and bringing the position to 109 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Advisornet Financial first reported a position in INSM in Q1 2023 and has held it in 10 quarters since. The position peaked at $160K in Q4 2025. 113 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Advisornet Financial held 109 shares of Insmed worth $11.6K as of Q2 2026.
  • Advisornet Financial bought 1 Insmed share in Q2 2026, an estimated $121.
  • Insmed made up ﹤0.01% of Advisornet Financial's portfolio in Q2 2026, its #1538 holding.
  • Advisornet Financial first reported a position in Insmed in Q1 2023 and has held it in 10 quarters since.
  • Advisornet Financial's Insmed position peaked at $160K in Q4 2025.
  • 113 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Advisornet Financial's 13F filing for Q2 2026, filed 23 Jul 2026.